Lynx Biosciences, LLC

MADISON, WI 53714

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $569K
First Award Date 03/01/16
Most Recent Award Date 04/04/17

Key Personnel

Last Name Name Awards Contact
PAK CHOROM PAK 2
DE GROOT THEODORUS DE 1

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 04/04/17 - 03/31/18

Multiple myeloma (MM) is a debilitating and currently incurable hematological malignancy. While the median survival has increased to 5 ? 7 years, MM patients ultimately relapse and become resistant to therapy. Once they reach this stage, it is often a trial and error process until an effective therapy can be found. Furthermore, the MM bone marro...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/16 - 02/28/17

? DESCRIPTION (provided by applicant) Multiple myeloma (MM) is a debilitating and currently incurable hematological malignancy. While the median survival has increased to 5 - 7 years, MM patients ultimately relapse and become resistant to therapy. Once they reach this stage, it is often a trial and error process until an effective therapy ca...